Cancer, Oncology & Supportive Care Conditions (177)
Solid tumor and hematologic oncology overviews, screening guidelines, and supportive symptom management.
40 Master Condition Specialty Hubs
Show All 40 Hubs ×Cancer, Oncology & Supportive Care Guides (177)
Clear All Filters ×Acute Lymphocytic Leukemia
What is leukemia? Leukemia is a term for cancers of the blood cells. Leukemia starts in blood-forming tissues such as the bone marrow. Your bone marrow makes the cells which will develop into white blood cells, red blood cells, and platelets. Each type of cell has a different job: White blood cells help your body fight infection Red blood cells deliver oxygen from your lungs to your tissues and organs Platelets help form clots to stop bleeding When you have leukemia, your bone marrow makes large numbers of abnormal cells. This problem most often happens with white blood cells. These abnormal cells build up in your bone marrow and blood.
Adenocarcinoma
Under Cancer, Oncology & Supportive Care diagnostic criteria (C80.1), workup for Adenocarcinoma integrates immunohistochemistry [Adenocarcinoma C80.1] with evidence-graded therapy tailored to Comprehensive Metabolic & in Adenocarcinoma (C80.1: Organ Function Panel) response.
Adenosquamous carcinoma
Physicians managing Adenosquamous carcinoma (C44.92; Cancer, Oncology & Supportive Care) utilize multidisciplinary tumor-board planning in Adenosquamous carcinoma (C44.92: (surgery) and objective Comprehensive Metabolic & in Adenosquamous carcinoma (C44.92: Organ Function Panel) targets (Preserved renal/hepatic clearance (C44.92)) to prevent progression and functional morbidity.
Adrenal Gland Cancer
Your adrenal, or suprarenal, glands are located on the top of each kidney. These glands produce hormones that you can't live without, including sex hormones and cortisol, which helps you respond to stress and has many other functions. A number of disorders can affect the adrenal glands , including tumors. Tumors can be either benign or malignant. Benign tumors aren't cancer. Malignant ones are. Most adrenal gland tumors are benign. They usually do not cause symptoms and may not require treatment. Malignant adrenal gland cancers are uncommon.
Anal Cancer
What is anal cancer? Your anus is the opening at the end of your large intestine. It is where stool (poop) leaves your body. The anus is formed partly from your outer layers of skin and partly from your intestine. Anal cancer is a type of cancer that forms in the tissues of your anus. Who is more likely to develop anal cancer? Anyone can get anal cancer, but you are more likely to develop it if you: You have an infection with high-risk HPV , especially if you have certain types. Most anal cancers are related to HPV infection. Have a weakened immune system , from conditions such as HIV or because of medicines you need to take after an organ transplant .
Antioxidants
Antioxidants are man-made or natural substances that may prevent or delay some types of cell damage. Antioxidants are found in many foods, including fruits and vegetables. They are also available as dietary supplements. Examples of antioxidants include: Beta-carotene Lutein Lycopene Selenium Vitamin A Vitamin C Vitamin E Vegetables and fruits are rich sources of antioxidants. There is good evidence that eating a diet with lots of vegetables and fruits is healthy and lowers risks of certain diseases. But it isn't clear whether this is because of the antioxidants, something else in the foods, or other factors.
Ataxia Telangiectasia
Ataxia-telangiectasia (A-T) is a rare, inherited disease. It affects the nervous system, immune system, and other body systems. Symptoms appear in young children, usually before age 5. They include: Ataxia - trouble coordinating movements Poor balance Slurred speech Tiny, red spider veins, called telangiectasias, on the skin and eyes Lung infections Delayed physical and sexual development People with A-T have an increased risk of developing diabetes and cancers, especially lymphoma and leukemia. Although it affects the brain, people with A-T usually have normal or high intelligence. A-T has no cure. Treatments might improve some symptoms.
Benign Tumors
Tumors are abnormal growths in your body. They can be either benign or malignant. Benign tumors aren't cancer. Malignant ones are. Benign tumors grow only in one place. They cannot spread or invade other parts of your body. Even so, they can be dangerous if they press on vital organs, such as your brain. Tumors are made up of extra cells. Normally, cells grow and divide to form new cells as your body needs them. When cells grow old, they die, and new cells take their place. Sometimes, this process goes wrong. New cells form when your body does not need them, and old cells do not die when they should. These extra cells can divide without stopping and may form a tumor.
Bile Duct Cancer
Your liver makes a digestive juice called bile. Your gallbladder stores it between meals. When you eat, your gallbladder pushes the bile into tubes called bile ducts . They carry the bile to your small intestine. The bile helps break down fat. It also helps the liver get rid of toxins and wastes. Bile duct cancer is rare. It can happen in the parts of the bile ducts that are outside or inside the liver. Cancer of the bile duct outside of the liver is much more common. Risk factors include having inflammation of the bile duct, ulcerative colitis , and some liver diseases.
Bladder Cancer
The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States. Symptoms include: Blood in your urine A frequent urge to urinate Pain when you urinate Low back pain Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, White, or male have a higher risk. Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.
Blood Disorders
Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets. Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. They can be acute or chronic. Many blood disorders are inherited. Other causes include other diseases, side effects of medicines, and a lack of certain nutrients in your diet.
Bone Cancer
Cancer that starts in a bone is uncommon. Cancer that has spread to the bone from another part of the body is more common. There are three types of bone cancer: Osteosarcoma - occurs most often between ages 10 and 19. It is more common in the knee and upper arm. Chondrosarcoma - starts in cartilage, usually after age 40 Ewing's sarcoma - occurs most often in children and teens under 19. It is more common in boys than girls. The most common symptom of bone cancer is pain. Other symptoms vary, depending on the location and size of the cancer. Surgery is often the main treatment for bone cancer. Other treatments may include amputation, chemotherapy, and radiation therapy.
Bone Marrow Diseases
Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains stem cells . The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting.
Bone Marrow Transplantation
Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into red blood cells, which carry oxygen throughout the body, white blood cells, which fight infections, and platelets, which help the blood to clot. A bone marrow transplant is a procedure that replaces a person's faulty bone marrow stem cells.
Bone tumor - benign
Bone tumor - benign (also termed Fibroid or Leiomyoma)—coded clinically as D16.9 across Cancer & Oncology guidelines—combines multidisciplinary tumor-board planning in Bone tumor - benign (D16.9: (surgery) with structured follow-up of Complete Blood Count in Bone tumor - benign (D16.9: (ANC, Hemoglobin, Platelets)) (Safe hematologic reserve (D16.9)).
Brain Tumors
A brain tumor is a growth of abnormal cells in the tissues of the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Some are primary brain tumors, which start in the brain. Others are metastatic, and they start somewhere else in the body and move to the brain. Brain tumors can cause many symptoms.
Brain malignancy
Physicians managing Brain malignancy (also termed Syrinx or Syringo) (C71.9; Cancer, Oncology & Supportive Care) utilize tissue biopsy with in Brain malignancy (C71.9: histopathology) and objective Complete Blood Count in Brain malignancy (C71.9: (ANC, Hemoglobin, Platelets)) targets (Safe hematologic reserve (C71.9)) to prevent progression and functional morbidity.
Brain tumor
Physicians managing Brain tumor (also termed Syrinx or Syringo) (D49.6; Cancer, Oncology & Supportive Care) utilize immunohistochemistry [Brain tumor D49.6] and objective Complete Blood Count in Brain tumor (D49.6: (ANC, Hemoglobin, Platelets)) targets (Safe hematologic reserve (D49.6)) to prevent progression and functional morbidity.
Breast Cancer
What is breast cancer? Breast cancer is a cancer that starts in breast tissue. It happens when cells in the breast change and grow out of control. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Sometimes the cancer does not spread any further. This is called "in situ." If the cancer spreads outside the breast, the cancer is called "invasive." It may just spread to nearby tissues and lymph nodes. Or the cancer may metastasize (spread to other parts of the body) through the lymph system or the blood.
Breast Diseases
What are breast diseases? Breast diseases include various conditions and changes in your breast. Most women experience breast changes at some time. Your age, hormone levels, and medicines you take may cause lumps, bumps, and discharges of fluids that are not breast milk. Although many women fear cancer , most breast changes are benign, meaning they are not cancer. These breast changes are known as benign breast disease. See your health care provider if you have a breast lump, pain, discharge, or skin irritation. Minor and serious breast problems often have similar symptoms and may need treatment.
Burkitt's tumor
Burkitt's tumor (also termed Fibroid or Leiomyoma) is an ICD-10-CM indexed diagnosis (C83.70) within Cancer, Oncology & Supportive Care. Clinical evaluation centers on targeted/immunotherapy [Burkitt's tumor C83.70] alongside serial Complete Blood Count in Burkitt's tumor (C83.70: (ANC, Hemoglobin, Platelets)) tracking (Safe hematologic reserve (C83.70)) to guide individualized care.
Cancer
What is cancer? Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer, while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of your body. The spread of cancer from one part of the body to another is called metastasis.
Cancer Alternative Therapies
What are complementary and alternative therapies for cancer care? You have many choices to make about your cancer treatment. One choice you might consider is using complementary and alternative medicine (CAM). CAM is the term for medical products and therapies that are not part of standard medical care. CAM for cancer treatment involves caring for your mind, body, and spirit. Some methods focus on your breathing or body movements to help you relax. Other CAM therapies may use special foods, supplements , or diets. Examples of CAM therapies include acupuncture , chiropractic , and herbal medicines .
Cancer Chemotherapy
What is cancer chemotherapy? Cancer chemotherapy is a type of cancer treatment. It uses medicines to destroy cancer cells. Normally, your body forms new cells as needed, replacing old cells that die. Cancer cells keep growing without control. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Chemotherapy works by killing the cancer cells, stopping them from spreading, or slowing their growth. Chemotherapy is used to: Treat cancer by curing the cancer, lessening the chance it will return, or stopping or slowing its growth.
Cancer Immunotherapy
What is immunotherapy? Immunotherapy is a cancer treatment that helps your immune system fight cancer. It is a type of biological therapy. Biological therapy uses substances made from living organisms or versions of these substances made in a lab. Immunotherapy isn't used for all cancers, and the response to treatment varies. If you're getting immunotherapy, your health care provider will monitor your treatment closely. When is immunotherapy used for cancer treatment? Immunotherapy isn't used as often as other cancer treatments, such as surgery, chemotherapy , and radiation therapy .
Cancer in Children
Cancer is a group of related diseases. In all types of cancer, some of the body's cells begin to divide without stopping and spread into surrounding tissues. Normally, new cells form as you need them, replacing old cells that die. Sometimes, this process goes wrong. New cells form when you don't need them, and old cells don't die when they should. The extra cells can form a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer. Malignant tumors are cancer, and the cancer cells can spread to nearby tissues. They can also break away and spread to other parts of the body.
Cancer--Living with Cancer
Learning to live with cancer Cancer is a common disease. Many Americans will be diagnosed with cancer during their lifetimes. Even though cancer may be life-threatening, many people have successful treatment. Others live with cancer for a very long time. For most people with cancer, learning to live with the disease is one of the biggest challenges they've ever faced. That's because having cancer touches just about every part of your life and the lives of those around you.
Carcinoid Tumors
Carcinoid tumors are rare, slow-growing cancers. They usually start in the lining of the digestive tract or in the lungs. They grow slowly and don't produce symptoms in the early stages. As a result, the average age of people diagnosed with digestive or lung carcinoids is about 60. In later stages the tumors sometimes produce hormones that can cause carcinoid syndrome. The syndrome causes flushing of the face and upper chest, diarrhea, and trouble breathing. Surgery is the main treatment for carcinoid tumors. If they haven't spread to other parts of the body, surgery can cure the cancer.
Carcinoid tumor
Cataloged under federal diagnostic code C43.0 in Cancer & Oncology, Carcinoid tumor (also termed Fibroid or Leiomyoma) requires multidisciplinary tumor-board planning in Carcinoid tumor (C43.0: (surgery) so specialists can calibrate treatment intensity against Pathology / Molecular in Carcinoid tumor (C43.0: Genomic Staging) benchmarks.
Carcinoid tumor - malignant
Cataloged under federal diagnostic code C50.0 in Cancer & Oncology, Carcinoid tumor - malignant (also termed Fibroid or Leiomyoma) requires immunohistochemistry [Carcinoid tumor - malignant C50.0] so specialists can calibrate treatment intensity against Complete Blood Count in Carcinoid tumor - malignant (C50.0: (ANC, Hemoglobin, Platelets)) benchmarks.
Carcinoma - Sertoli cell
Cataloged under federal diagnostic code D27.9 in Cancer & Oncology, Carcinoma - Sertoli cell requires tissue biopsy with in Carcinoma - Sertoli cell (D27.9: histopathology) so specialists can calibrate treatment intensity against Comprehensive Metabolic & in Carcinoma - Sertoli cell (D27.9: Organ Function Panel) benchmarks.
Carcinoma - giant cell
Within Cancer, Oncology & Supportive Care practice, Carcinoma - giant cell (ICD-10 C34.90) is stratified through targeted/immunotherapy [Carcinoma - giant cell C34.90], pairing targeted symptom control with longitudinal Comprehensive Metabolic & in Carcinoma - giant cell (C34.90: Organ Function Panel) surveillance.
Carcinoma - metastatic
Within Cancer, Oncology & Supportive Care practice, Carcinoma - metastatic (also termed Metastasis or Metastases) (ICD-10 C79.9) is stratified through multidisciplinary tumor-board planning in Carcinoma - metastatic (C79.9: (surgery), pairing targeted symptom control with longitudinal Pathology / Molecular in Carcinoma - metastatic (C79.9: Genomic Staging) surveillance.
Carcinoma - pseudosarcomatous
Carcinoma - pseudosarcomatous—coded clinically as C80.1 across Cancer & Oncology guidelines—combines targeted/immunotherapy [Carcinoma - pseudosarcomatous C80.1] with structured follow-up of Pathology / Molecular in Carcinoma - pseudosarcomatous (C80.1: Genomic Staging) (Guideline-concordant surveillance (C80.1)).
Carcinoma - verrucous
Cataloged under federal diagnostic code C44.721 in Cancer & Oncology, Carcinoma - verrucous (also termed Warts or Verruca) requires immunohistochemistry [Carcinoma - verrucous C44.721] so specialists can calibrate treatment intensity against Pathology / Molecular in Carcinoma - verrucous (C44.721: Genomic Staging) benchmarks.
Cauda equina tumor
Within Cancer, Oncology & Supportive Care practice, Cauda equina tumor (also termed Fibroid or Leiomyoma) (ICD-10 D49.7) is stratified through radiation) paired with in Cauda equina tumor (D49.7: proactive supportive symptom), pairing targeted symptom control with longitudinal Comprehensive Metabolic & in Cauda equina tumor (D49.7: Organ Function Panel) surveillance.
Cerebellar Disorders
When you play the piano or hit a tennis ball you are activating the cerebellum. The cerebellum is the area of the brain that controls coordination and balance. Problems with the cerebellum include: Cancer Genetic disorders Ataxias - failure of muscle control in the arms and legs that result in movement disorders Degeneration - disorders caused by brain cells decreasing in size or wasting away Treatment of cerebellar disorders depends on the cause. In some cases, there is no cure but treatment may help with symptoms.
Cervical Cancer
What is cervical cancer? Cervical cancer is cancer that starts in the cells of the cervix. The cervix is part of the female reproductive system. It is the lower, narrow end of the uterus (womb), which opens into the vagina (birth canal). Cervical cancer usually develops slowly. Before cervical cells become cancer, they start to look abnormal. These cells are called "precancers." If they aren't destroyed or removed, they may become cancer cells that grow out of control and spread to other parts of your body. Screening tests for cervical cancer can help find abnormal cells so you can get treatment to prevent cervical cancer.
Childhood Brain Tumors
Brain tumors are abnormal growths inside the skull. They are among the most common types of childhood cancers . Some are benign tumors, which aren't cancer. They can still be serious. Malignant tumors are cancerous. Childhood brain and spinal cord tumors can cause headaches and other symptoms. However, other conditions can also cause the same symptoms.
Chondrosarcoma
Chondrosarcoma—coded clinically as C41.9 across Cancer & Oncology guidelines—combines targeted/immunotherapy [Chondrosarcoma C41.9] with structured follow-up of Pathology / Molecular in Chondrosarcoma (C41.9: Genomic Staging) (Guideline-concordant surveillance (C41.9)).
Choriocarcinoma
Clinical triage of Choriocarcinoma (C34.5) in Cancer & Oncology relies on immunohistochemistry [Choriocarcinoma C34.5], guiding step-wise therapeutic adjustments toward Complete Blood Count in Choriocarcinoma (C34.5: (ANC, Hemoglobin, Platelets)) (Safe hematologic reserve (C34.5)).
Colorectal Cancer
What is colorectal cancer? Colorectal cancer is cancer that develops in the tissues of the colon or rectum. Your colon and rectum are part of your digestive system: Your colon is the first and longest part of your large intestine. It absorbs water and some nutrients from foods. It also changes the leftover waste products into stool (poop). Your rectum is the lower part of your large intestine. It's where your body stores stool. Cancer that begins in the colon is called colon cancer, and cancer that begins in the rectum is called rectal cancer. Cancer that affects either of these parts may also be called colorectal cancer.
Complementary and Integrative Medicine
Many Americans use medical treatments that are not part of mainstream medicine. When you are using these types of care, it may be called complementary, integrative, or alternative medicine. Complementary medicine is used together with mainstream medical care. An example is using acupuncture to help with side effects of cancer treatment. When health care providers and facilities offer both types of care, it is called integrative medicine. Alternative medicine is used instead of mainstream medical care. The claims that non-mainstream practitioners make can sound promising. However, researchers do not know how safe many of these treatments are or how well they work.
Cutaneous B cell lymphoma
Within Cancer, Oncology & Supportive Care practice, Cutaneous B cell lymphoma (also termed Skin or Dermis) (ICD-10 C85.10) is stratified through tissue biopsy with in Cutaneous B cell lymphoma (C85.10: histopathology), pairing targeted symptom control with longitudinal Pathology / Molecular in Cutaneous B cell lymphoma (C85.10: Genomic Staging) surveillance.
Cystadenocarcinoma
For patients presenting with Cystadenocarcinoma (ICD-10-CM C56.9), Cancer, Oncology & Supportive Care protocols prioritize tissue biopsy with in Cystadenocarcinoma (C56.9: histopathology) paired with baseline and interval Comprehensive Metabolic & in Cystadenocarcinoma (C56.9: Organ Function Panel) assessment.
Di Guglielmo's syndrome
Di Guglielmo's syndrome (also termed Disorder or Syndrome) is an ICD-10-CM indexed diagnosis (C94.00) within Cancer, Oncology & Supportive Care. Clinical evaluation centers on tissue biopsy with in Di Guglielmo's syndrome (C94.00: histopathology) alongside serial Comprehensive Metabolic & in Di Guglielmo's syndrome (C94.00: Organ Function Panel) tracking (Preserved renal/hepatic clearance (C94.00)) to guide individualized care.
Ductal carcinoma
Within Cancer, Oncology & Supportive Care practice, Ductal carcinoma (also termed Ductal or Ducts) (ICD-10 C80.1) is stratified through tissue biopsy with in Ductal carcinoma (C80.1: histopathology), pairing targeted symptom control with longitudinal Complete Blood Count in Ductal carcinoma (C80.1: (ANC, Hemoglobin, Platelets)) surveillance.
Electromagnetic Fields
Electric and magnetic fields (EMFs), also called radiation , are areas of energy that surround electrical devices. Everyday sources of EMFs include: Power lines Electrical wiring Microwave ovens Computers Cell phones Some people worry about EMF exposure and cancer. Some studies have found a link between EMF exposure and a higher risk of childhood leukemia, but other studies have not. Other studies have not found proof that EMF exposure causes other childhood cancers. Studies in adults did not prove that EMF exposure causes cancer. Some people worry that cell (wireless) phones cause cancer or other health problems.
Ependymoma
Ependymoma—coded clinically as C71.9 across Cancer & Oncology guidelines—combines targeted/immunotherapy [Ependymoma C71.9] with structured follow-up of Pathology / Molecular in Ependymoma (C71.9: Genomic Staging) (Guideline-concordant surveillance (C71.9)).
Esophageal Cancer
The esophagus is a hollow tube that carries food and liquids from your throat to your stomach. Early esophageal cancer usually does not cause symptoms. Later, you may have symptoms such as: Painful or difficult swallowing Weight loss A hoarse voice or cough that doesn't go away You're at greater risk for getting esophageal cancer if you smoke, drink heavily, or have acid reflux . Your risk also goes up as you age Your doctor uses imaging tests and a biopsy to diagnose esophageal cancer. Treatments include surgery, radiation, and chemotherapy. You might also need nutritional support , since the cancer or treatment may make it hard to swallow.
Ewing's sarcoma
Within Cancer, Oncology & Supportive Care practice, Ewing's sarcoma (ICD-10 C41.9) is stratified through multidisciplinary tumor-board planning in Ewing's sarcoma (C41.9: (surgery), pairing targeted symptom control with longitudinal Complete Blood Count in Ewing's sarcoma (C41.9: (ANC, Hemoglobin, Platelets)) surveillance.
Eye Cancer
Cancer of the eye is uncommon. It can affect the outer parts of the eye, such as the eyelid, which are made up of muscles, skin and nerves. If the cancer starts inside the eyeball it's called intraocular cancer. The most common intraocular cancers in adults are melanoma and lymphoma. The most common eye cancer in children is retinoblastoma, which starts in the cells of the retina. Cancer can also spread to the eye from other parts of the body. Treatment for eye cancer varies by the type and by how advanced it is. It may include surgery, radiation therapy, freezing or heat therapy, or laser therapy.
Fallopian tube cancer
Within Cancer, Oncology & Supportive Care practice, Fallopian tube cancer (also termed Tube or Line) (ICD-10 C57.00) is stratified through tissue biopsy with in Fallopian tube cancer (C57.00: histopathology), pairing targeted symptom control with longitudinal Comprehensive Metabolic & in Fallopian tube cancer (C57.00: Organ Function Panel) surveillance.
Ganglioneuroblastoma
Within Cancer, Oncology & Supportive Care practice, Ganglioneuroblastoma (ICD-10 C74.90) is stratified through tissue biopsy with in Ganglioneuroblastoma (C74.90: histopathology), pairing targeted symptom control with longitudinal Comprehensive Metabolic & in Ganglioneuroblastoma (C74.90: Organ Function Panel) surveillance.
Giant cell tumor of soft parts
Within Cancer, Oncology & Supportive Care practice, Giant cell tumor of soft parts (also termed Fibroid or Leiomyoma) (ICD-10 D49.2) is stratified through tissue biopsy with in Giant cell tumor of soft parts (D49.2: histopathology), pairing targeted symptom control with longitudinal Pathology / Molecular in Giant cell tumor of soft parts (D49.2: Genomic Staging) surveillance.
Giant cell tumor tendon sheath
Designated in federal medical registries as M65.88, Giant cell tumor tendon sheath (also termed Fibroid or Leiomyoma) falls under Cancer & Oncology management, where immunohistochemistry [Giant cell tumor tendon sheath M65.88] establishes baseline severity and rules out diagnostic mimics.
Glioblastoma multiforme
Under Cancer, Oncology & Supportive Care diagnostic criteria (C71.9), workup for Glioblastoma multiforme integrates immunohistochemistry [Glioblastoma multiforme C71.9] with evidence-graded therapy tailored to Pathology / Molecular in Glioblastoma multiforme (C71.9: Genomic Staging) response.
Glucagonoma
Physicians managing Glucagonoma (C25.4; Cancer, Oncology & Supportive Care) utilize targeted/immunotherapy [Glucagonoma C25.4] and objective Pathology / Molecular in Glucagonoma (C25.4: Genomic Staging) targets (Guideline-concordant surveillance (C25.4)) to prevent progression and functional morbidity.
Glucagonoma - malignant
Within Cancer, Oncology & Supportive Care practice, Glucagonoma - malignant (also termed Metastasis or Metastases) (ICD-10 C25.4) is stratified through immunohistochemistry [Glucagonoma - malignant C25.4], pairing targeted symptom control with longitudinal Comprehensive Metabolic & in Glucagonoma - malignant (C25.4: Organ Function Panel) surveillance.
Granular cell tumor
Within Cancer, Oncology & Supportive Care practice, Granular cell tumor (also termed Fibroid or Leiomyoma) (ICD-10 D21.9) is stratified through tissue biopsy with in Granular cell tumor (D21.9: histopathology), pairing targeted symptom control with longitudinal Complete Blood Count in Granular cell tumor (D21.9: (ANC, Hemoglobin, Platelets)) surveillance.